# Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care

- Link: https://www.thailand-business-news.com/pr-news/global-genomics-and-multi-omics-leader-novogene-to-establish-its-first-australian-laboratory-at-cabrini-health-accelerating-access-to-precision-cancer-care
- Published: 2026-08-28T03:00:00+07:00
- Author: PR Newswire

MELBOURNE, Australia, Aug. 28, 2026 /PRNewswire/ — Global multi-omics leader Novogene
is establishing its first Australian laboratory at Cabrini Health, bringing advanced
genomic capabilities closer to Australian patients and researchers, reducing the
wait for genomic test results that can inform cancer treatment decisions, and accelerating
access to personalised treatment and precision diagnostic testing.

 [](https://mmx.prnasia.com/media/MS1976829/20260827035513EDT_image_1.jpg?id=OA2915944&p=medium600)

The joint laboratory will be strategically located within the clinical and cancer
research precinct at Cabrini Malvern. Expected to open in 2027, it will become Australia’s
first genomics laboratory co-located within a private hospital.

Novogene’s expansion into Australia marks a significant boost to Victoria’s precision
medicine capabilities, bringing industry-leading expertise, technologies and workflows
in high-throughput sequencing and advanced multi-omics.

Cabrini’s cancer services deliver approximately 30,000 treatments and 4,000 diagnoses
each year, while its clinical trials program provides patients with access to innovative
new therapies across approximately 100 active trials. By integrating genomic testing
within the clinical environment, the laboratory is expected to enable faster turnaround
from biopsy to genomic results, supporting more timely clinical decision-making 
and treatment initiation.

Professor Gary Richardson OAM, Group Director of Cabrini Research, Neil Beauglehall
Endowed Chair of Medical Oncology Research, and medical oncologist at Cabrini Health,
said the collaborative service with Novogene would deliver significant immediate
and long-term benefits for patients.

"The laboratory will allow us to provide genomic results within days and connect
patients more rapidly with effective treatment options, including access to clinical
trials," Professor Richardson said.

"For our cancer patients, particularly those living with rare and complex cancers,
that means faster access to potentially life-saving treatments. Looking ahead, the
knowledge we generate from this genomic information will help us develop new diagnostic
tools and targeted therapies that will redefine how we deliver care to patients 
with cancer."

The precision oncology program underpinning the new laboratory has been made possible
with the support of philanthropic and government investment.

"We’ve been fortunate to secure significant investment, including a $10 million 
grant from the PMF Foundation and a $5 million Australian Government grant, to establish
a precision oncology program that will help patients access genomic testing and 
personalised treatments," Cabrini Chief Executive Sue Williams said.

"Together with Novogene, this clinically integrated service will improve the quality
of our cancer services and position Cabrini as a national leader in precision oncology."

Justin Lee, Vice President of Novogene Asia-Pacific, Middle East and Africa (AMEA),
said Cabrini’s leadership in cancer care and research, together with its close connections
to universities and healthcare consortia across Melbourne, made it an ideal location
for Novogene’s first Australian laboratory.

"Building our first Australian laboratory at Cabrini Health represents an important
milestone in Novogene’s long-term commitment to Australia," he said. "By bringing
our advanced genomics and multi-omics capabilities closer to Australian clinicians,
researchers and patients, we aim to enable deeper collaboration and accelerate the
translation of scientific discoveries into meaningful clinical impact. We will also
strengthen our local presence by hiring and training Australian talent, establishing
a robust quality management system, and fostering stronger local collaborations 
that leverage Australia’s world-class clinical research ecosystem."

Dr Olivia He, Country Director of Novogene Australia, said the laboratory would 
strengthen Novogene’s ability to support healthcare and research partners across
Australia.

"Establishing this capability in Melbourne is an important step in strengthening
our presence and bringing us closer to the clinicians and researchers we work with,"
she said. "It will enable faster, more responsive support and deeper collaboration
as precision medicine continues to advance. With this local capability, we can better
support clinical trials and pursue joint development with our Australian partners."

**About Cabrini Health**

[Cabrini Health](https://www.cabrini.com.au/) is a Catholic, not-for-profit private
health service located in Melbourne’s southeast. Inspired by the mission and ethic
of care of the Cabrini Sisters, they have been providing quality, compassionate 
care to our community for more than 75 years.

Today, Cabrini employs more than 4,500 people and supports almost 100,000 episodes
of care every year.  With hospitals in Malvern, Brighton and Elsternwick, Cabrini
offers a comprehensive range of acute, rehabilitation, palliative care, mental health
and homecare services.

Our highly-skilled staff and specialists incorporate clinical research, innovative
models of care and state-of-the-art technology to deliver the best possible care
and outcomes for our patients.

**About Novogene**

[Novogene ](https://amea.novogene.com/)is a global provider of life sciences products
and solutions, built on core strengths in multi-omics and powered by automation,
advanced computing and artificial intelligence. With one of the world’s largest 
sequencing capacities, Novogene has processed millions of samples and supports researchers
and healthcare organisations worldwide. Novogene delivers integrated solutions across
the life sciences value chain, supporting precision health, clinical testing, drug
development, biomanufacturing and agricultural breeding. Operating across six continents
and approximately 90 countries and regions, Novogene serves more than 8,000 customers
through a global network of research, production and service facilities, complemented
by local expertise and support. For more information, visit [amea.novogene.com](https://amea.novogene.com/).

 

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care ](http://www.prnasia.com/story/archive/5035099_AE35099_0?rand=184833)